BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26861804)

  • 21. Secondary leukemia after chemotherapy and/or radiotherapy for gynecologic neoplasia.
    Shimada T; Saito T; Okadome M; Shimamoto K; Ariyoshi K; Eto T; Tomita Y; Kodama K
    Int J Gynecol Cancer; 2014 Feb; 24(2):178-83. PubMed ID: 24407580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study.
    Chaplain G; Milan C; Sgro C; Carli PM; Bonithon-Kopp C
    J Clin Oncol; 2000 Aug; 18(15):2836-42. PubMed ID: 10920131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronous bilateral non-Hodgkin's diffuse large B-cell lymphoma of the breast and left breast invasive ductal carcinoma: a case report and review of literature.
    Liu W; Zhu H; Zhou X
    Int J Clin Exp Pathol; 2014; 7(10):7042-8. PubMed ID: 25400793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.
    Fisher B; Rockette H; Fisher ER; Wickerham DL; Redmond C; Brown A
    J Clin Oncol; 1985 Dec; 3(12):1640-58. PubMed ID: 3906049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma--De Novo Occurrence or Transformation.
    Gajendra S; Jha B; Goel S; Sahni T; Dorwal P; Sachdev R
    Turk J Haematol; 2015 Dec; 32(4):371-2. PubMed ID: 26376833
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
    Muss HB; Berry DA; Cirrincione C; Budman DR; Henderson IC; Citron ML; Norton L; Winer EP; Hudis CA;
    J Clin Oncol; 2007 Aug; 25(24):3699-704. PubMed ID: 17704418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary diffuse large B-cell lymphoma after chemotherapy for acute myeloid leukemia: looking for the unexpected diagnosis.
    Ririe MR; Florell SR; Miles RR; Duffy KL
    Am J Dermatopathol; 2014 Jul; 36(7):e125-8. PubMed ID: 24950422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary breast lymphoma.
    Cheah CY; Campbell BA; Seymour JF
    Cancer Treat Rev; 2014 Sep; 40(8):900-8. PubMed ID: 24953564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pancytopenia and macular rash in a woman with a history of breast cancer].
    Jacobi D; Vidal C; Gironet N; Machet MC; Machet L
    Rev Med Interne; 2003 Jun; 24(6):399-400. PubMed ID: 12814830
    [No Abstract]   [Full Text] [Related]  

  • 30. The leukemic phase of histiocytic lymphoma: report of four cases.
    Rehman KL; Rosner F; Grünwald HW
    Am J Med Sci; 1974 Dec; 268(6):353-9. PubMed ID: 4616629
    [No Abstract]   [Full Text] [Related]  

  • 31. Bilateral primary breast lymphoma--case report.
    Vasilakaki T; Zizi-Sermpetzoglou A; Katsamagkou E; Grammatoglou X; Petrakopoulou N; Glava C
    Eur J Gynaecol Oncol; 2006; 27(6):623-4. PubMed ID: 17290599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options.
    Aviv A; Tadmor T; Polliack A
    Ann Oncol; 2013 Sep; 24(9):2236-44. PubMed ID: 23712546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
    Roberts E; Oncale M; Safah H; Schmieg J
    J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffuse large B-cell lymphoma of the breast: a distinct entity?
    Bierman PJ; Villanueva ML; Armitage JO
    Ann Oncol; 2008 Feb; 19(2):201-2. PubMed ID: 18187483
    [No Abstract]   [Full Text] [Related]  

  • 36. Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.
    Wei JL; Jiang YZ; Shao ZM
    Int J Clin Oncol; 2019 Aug; 24(8):934-940. PubMed ID: 30888527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of Richter's syndrome].
    Mukhina MS; Vorob'ev SL
    Arkh Patol; 2013; 75(3):48-51. PubMed ID: 24006775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of adjuvant chemotherapy in breast cancer.
    Forbes JF
    Acta Oncol; 1992; 31(2):243-50. PubMed ID: 1622641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast.
    Seker M; Bilici A; Ustaalioglu BO; Yilmaz B; Ozturk B; Ünal A; Dane F; Ozdemir NY; Elkiran ET; Kalender ME; Gumus M; Benekli M
    Arch Gynecol Obstet; 2011 Aug; 284(2):405-9. PubMed ID: 20872226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.
    Fornander T; Hellström AC; Moberger B
    J Natl Cancer Inst; 1993 Nov; 85(22):1850-5. PubMed ID: 8230266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.